Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HCW Biologics (HCWB) Gross Profit (2022 - 2025)

Historic Gross Profit for HCW Biologics (HCWB) over the last 4 years, with Q3 2025 value amounting to $3121.0.

  • HCW Biologics' Gross Profit fell 9634.05% to $3121.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $84405.0, marking a year-over-year decrease of 9255.09%. This contributed to the annual value of $959403.0 for FY2024, which is 7121.19% up from last year.
  • According to the latest figures from Q3 2025, HCW Biologics' Gross Profit is $3121.0, which was down 9634.05% from $1310.0 recorded in Q2 2025.
  • HCW Biologics' Gross Profit's 5-year high stood at $1.8 million during Q1 2022, with a 5-year trough of $1013.0 in Q1 2025.
  • In the last 4 years, HCW Biologics' Gross Profit had a median value of $166800.0 in 2022 and averaged $274105.7.
  • In the last 5 years, HCW Biologics' Gross Profit skyrocketed by 480502.67% in 2024 and then plummeted by 9983.52% in 2025.
  • Quarter analysis of 4 years shows HCW Biologics' Gross Profit stood at $268304.0 in 2022, then fell by 5.84% to $252645.0 in 2023, then tumbled by 68.75% to $78961.0 in 2024, then tumbled by 96.05% to $3121.0 in 2025.
  • Its last three reported values are $3121.0 in Q3 2025, $1310.0 for Q2 2025, and $1013.0 during Q1 2025.